Ata Ur Rehman Maaz

Ata Ur Rehman Maaz

Auto-generated profile, based on publicly available information

Ata Ur Rehman Maaz

Division of Hematology Oncology, Department of Pediatrics, Sidra Medicine, Doha, Qatar

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2020 in Child's Nervous System
Verified
Journal Article
Open access
PDF file
AMAta U. R. Maaz
Ata U. R. Maaz
TYTayseer Yousif
Tayseer Yousif
ASAyman Saleh
Ayman Saleh
IPIan Pople
Ian Pople
KAKhalid Al-Kharazi
Khalid Al-Kharazi
MMMuzaffar Malik
Muzaffar Malik
Introduction: There are no previous published reports on primary pediatric tumors of the central nervous system (CNS) in Qatar. We undertook this retrospective cohort study to review the diagnosis of CNS tumors in children in Qatar to analyze the presentation characteristics including symptoms, referral pathways, and time to diagnosis. Methods: All children registered with Pediatric Neuro-Oncology service (PNOS) were included in the study. Data from the time of diagnosis (October 2007 to February 2020) were reviewed retrospectively. Presenting symptoms were recorded and pre-diagnosis symptom interval (PSI) was calculated from the onset of the first symptom to the date of diagnostic imaging. Results: Of the 61 children registered with PNOS during the study period, 51 were included in the final analysis. Ten children were excluded because they were either diagnosed outside Qatar (n = 7) or were asymptomatic at the time of diagnosis (n = 3). The median age was 45 (range 1–171) months. Common tumor types included low-grade glioma (LGG) (47.1%) and medulloblastoma/primitive neuro-ectodermal tumors (PNET) (23.5%). Nine children had an underlying neurocutaneous syndrome. Thirty-eight patients (74.5%) had at least one previous contact with healthcare (HC) professional, but 27 (52%) were still diagnosed through the emergency department (ED). Presenting symptoms included headache, vomiting (36.2%), oculo-visual symptoms (20.6%), motor weakness (18.9%), seizures, ataxia (17.2% each), irritability, cranial nerve palsies (12% each), and endocrine symptoms (10.3%). Median PSI was 28 days (range 1–845 days) for all CNS tumors. Longest PSI was seen with germ cell tumors (median 146 days), supratentorial location (39 days), and age above 3 years (30 days). Tumor characteristics of biological behavior (high-grade tumor) and location (infratentorial) were significantly associated with shorter PSI, as were presenting symptoms of ataxia, head tilt, and altered consciousness. Conclusions: Although overall diagnostic times were acceptable, some tumor types were diagnosed after a significant delay. The awareness campaign, such as the “HeadSmart” campaign in the United Kingdom (UK), can improve diagnostic times in Qatar. Further research is required to better understand the reasons for the delay.

28 April 2022 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
NMNaureen Mushtaq
Naureen Mushtaq
FMFatima Mustansir
Fatima Mustansir
KMKhurram Minhas
Khurram Minhas
SUSadia Usman
Sadia Usman
BQBilal Mazhar Qureshi
Bilal Mazhar Qureshi
EBEric Bouffet
Eric Bouffet

14 November 2023 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
MKMuhammad Saghir Khan
Muhammad Saghir Khan
AMAta Ur Rehman Maaz
Ata Ur Rehman Maaz
AQAbid Quddus Qazi
Abid Quddus Qazi
SASophia Aslam
Sophia Aslam
SRShazia Riaz
Shazia Riaz
NSNajma Shaheen
Najma Shaheen

1 July 2025 in JCO Global Oncology
Verified
Journal Article
Closed access
EBEssra' Al Badarin
Essra' Al Badarin
OCOmar Chamdine
Omar Chamdine
MEMoatasem Elayadi
Moatasem Elayadi
AAAbeer Al-Battashi
Abeer Al-Battashi
MNMohammed Al Nuaimi
Mohammed Al Nuaimi
NANisreen Amayiri
Nisreen Amayiri
PURPOSE: Video teleconferencing in neuro-oncology is feasible and sustainable. The well-established, 20-year long monthly teleconference between King Hussein Cancer Center (KHCC), Jordan, and SickKids, Canada, is an example. Since 2018, several regional centers joined these meetings to discuss their patients' management plans. We aim to evaluate this experience. METHODS: We reviewed the minutes of 56 meetings (2018-2023). Preconference local treatment plans were compared with postconference recommendations. We documented the implementation of recommendations and the impact perceived by the treating oncologists. RESULTS: Two hundred fifty-one patients were discussed: 137 from Jordan and 114 from eight other countries. Four of the 14 participating oncologists had formal pediatric neuro-oncology training. Of the 227 patients (90%), where the local multidisciplinary team had suggested a preconference plan, the teleconference recommendations concurred with the proposed plan in 50% of cases, agreed on it and proposed an alternative option in 18%, and disagreed in 32%. The difference in recommendations mostly affected the proposed treatment modality. In 64% of discordant plans and 50% of alternative plans, the treating team applied the recommendations. The main challenges in applying the recommendations were attributed to patient-related factors (51%), local team consensus on a different plan (26%), or logistic difficulties (23%). The high patient load, longer involvement in teleconferencing, formal neuro-oncology training, and well-established multidisciplinary team helped the KHCC team formulate more concordant plans. CONCLUSION: This experience illustrates the potential benefit for physicians to get an expert opinion on challenging cases. The participating oncologists valued the shared educational experience, especially those related to molecular testing and treatment implications. Joining such regional teleconferences is of particular importance to centers with small patient volume or those lacking a pediatric neuro-oncologist.

6 November 2024 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
MAMunira Aden
Munira Aden
MFMahmoud O. Fawzi
Mahmoud O. Fawzi
DPDebra Prosser
Debra Prosser
MAMuhammad Ather
Muhammad Ather
MRMehak Raja
Mehak Raja
AMAta U. Maaz
Ata U. Maaz
Objectives: To review the clinical and radiological correlation of the central nervous system manifestations of tuberous sclerosis complex (TSC). Methods: All patients under the age of 18 years with TSC seen at the Department of Pediatrics, Sidra Medicine, Doha, Qatar, between January 2003 and February 2021 were included in this retrospective study. Severity of epilepsy was determined using the early childhood epilepsy severity score (E-CHESS) tool. Results: The study sample included 38 patients (50% male), 8 (21%) of whom were native to Qatar. The median age at diagnosis was 4 (range: 0-72) months. A family history of TSC was present in 10 (26%) cases, while 33 (86%) patients had a TSC2 gene mutation. Common presentations included seizures (79%), rhabdomyoma (26%), and developmental delay (13%). On MRI scans, cortical tubers were seen in all patients, subependymal nodules in 37 (97%), and subependymal giant cell astrocytoma was diagnosed in 8 (21%) cases. A total of 30 children developed epilepsy, 9 of whom had favorable and 21 had unfavorable E-CHESS scores, and 6 required pharmaceutical management. A total of 13 children were diagnosed with autistic spectrum disorder and 12 with attention deficit hyperactivity disorder. Conclusion: Multidisciplinary management and further research is needed to optimize the care and quality of life of TSC affected individuals and their families.

26 June 2020
Verified
Preprint
Open access
AMAta Maaz
Ata Maaz
JOJim O'Doherty
Jim O'Doherty
MDMehdi Djekidel
Mehdi Djekidel
Background: MIBG imaging has been the standard for neuroblastoma staging following its discovery 4 decades ago. Novel agents such as 18F-FDOPA and 68Ga-DOTATATE are being widely used nowadays in academic centers. In the midst of the COVID-19 pandemic, procurement of MIBG has proved particularly challenging, necessitating the use of 68Ga DOTATATE positron emission tomography. Methods: 68Ga-DOTATATE PET/CT imaging was carried out for completion of staging investigation for three pediatric patients who were diagnosed with Neuroblastoma at our institution, as 123Iodine MIBG became unavailable during the pandemic. Results: 68Ga-DOTATATE PET/CT scans were carried out in all three pediatric patients without any complications. All patients showed 68Gallium DOTATATE avid disease. PET/CT scans showed better spatial resolution, increased lesion contrast and demonstrated high accuracy in staging neuroblastoma patients in concordance with current EANM guidelines. Conclusion: 68Ga-DOTATATE PET/CT imaging can be reliably used as an alternative to MIBG for staging and evaluation of patients with neuroblastoma. Impact may be best in high risk disease.